Blueprint Medicines Corp Q3 2022 Earnings Call & Investor Day Transcript - Thomson StreetEvents

Blueprint Medicines Corp Q3 2022 Earnings Call & Investor Day Transcript

Blueprint Medicines Corp Q3 2022 Earnings Call & Investor Day Transcript - Thomson StreetEvents
Blueprint Medicines Corp Q3 2022 Earnings Call & Investor Day Transcript
Published Nov 01, 2022
48 pages (39018 words) — Published Nov 01, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of BPMC.OQ earnings conference call or presentation 1-Nov-22 12:30pm GMT

  
Brief Excerpt:

...Operator Please welcome to the stage Senior Vice President, Investor Relations, Jim Baker. Unidentified Company Representative Good morning, everyone. Thank you for joining us in the room and on the webcast. We know that your time is really important. And we're grateful that you're choosing to spend your morning with us today. We're also thankful to all the Blueprint employees, who contributed to the presentation you're about to see and are listening in from home. This morning, we announced financial results for the third quarter. And during the presentation today, we're excited to share a number of updates and our vision for achieving precision at scale. Our presenters include Kate Haviland, our Chief Executive Officer; Dr. Philina Lee, our Chief Commercial Officer; Dr. Becker Hewes, our Chief Medical Officer; Dr. Fouad Namouni, our President of R&D; Dr. Percy Carter, our Chief Scientific Officer; and Christy Rossi, our Chief Operating Officer; Mike Landsittel, our Chief Financial Officer...

  
Report Type:

Transcript

Source:
Company:
Blueprint Medicines Corp
Ticker
BPMC.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Blueprint Medicines Corp at Stifel Targeted Oncology Days (Virtual) Transcript – 2023-04-25 – US$ 54.00 – Edited Transcript of BPMC.OQ presentation 25-Apr-23 3:30pm GMT

Blueprint Medicines Corp at Barclays Global Healthcare Conference Transcript – 2023-03-15 – US$ 54.00 – Edited Transcript of BPMC.OQ presentation 15-Mar-23 6:35pm GMT

Blueprint Medicines Corp To Discuss The Registrational PIONEER Trial Data Of AYVAKIT In Indolent SM Call Transcript – 2023-02-27 – US$ 54.00 – Edited Transcript of BPMC.OQ conference call or presentation 27-Feb-23 1:00pm GMT

Blueprint Medicines Corp Q4 2022 Earnings Call Transcript – 2023-02-16 – US$ 54.00 – Edited Transcript of BPMC.OQ earnings conference call or presentation 16-Feb-23 1:00pm GMT

Blueprint Medicines Corp at JPMorgan Healthcare Conference Transcript – 2023-01-11 – US$ 54.00 – Edited Transcript of BPMC.OQ presentation 11-Jan-23 12:30am GMT

Blueprint Medicines Corporate call Transcript – 2022-08-17 – US$ 54.00 – Edited Transcript of BPMC.OQ conference call or presentation 17-Aug-22 12:00pm GMT

Blueprint Medicines Corp Q2 2022 Earnings Call Transcript – 2022-08-02 – US$ 54.00 – Edited Transcript of BPMC.OQ earnings conference call or presentation 2-Aug-22 12:00pm GMT

Blueprint Medicines Corp Collaborations with Sixth Street and Royalty Pharma - Corporate Call Transcript – 2022-06-30 – US$ 54.00 – Edited Transcript of BPMC.OQ conference call or presentation 30-Jun-22 12:30pm GMT

Blueprint Medicines Corp at JMP Securities Life Sciences Conference (Virtual) Transcript – 2022-06-16 – US$ 54.00 – Edited Transcript of BPMC.OQ presentation 16-Jun-22 4:30pm GMT

Blueprint Medicines Corp at Goldman Sachs Global Healthcare Conference Transcript – 2022-06-16 – US$ 54.00 – Edited Transcript of BPMC.OQ presentation 16-Jun-22 3:40pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Blueprint Medicines Corp Q3 2022 Earnings Call & Investor Day Transcript" Nov 01, 2022. Alacra Store. May 03, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2022-Blueprint-Medicines-Corp-Earnings-Call-Investor-Day-T15363011>
  
APA:
Thomson StreetEvents. (2022). Blueprint Medicines Corp Q3 2022 Earnings Call & Investor Day Transcript Nov 01, 2022. New York, NY: Alacra Store. Retrieved May 03, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2022-Blueprint-Medicines-Corp-Earnings-Call-Investor-Day-T15363011>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.